Publications

Detailed Information

The Korean undiagnosed diseases program phase I: expansion of the nationwide network and the development of long-term infrastructure

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors

Kim, Soo Y.; Lee, Seungbok; Woo, Hyewon; Han, Jiyeon; Ko, Young J.; Shim, Youngkyu; Park, Soojin; Jang, Se S.; Lim, Byung C.; Ko, Jung M.; Kim, Ki J.; Cho, Anna; Kim, Hunmin; Hwang, Hee; Choi, Ji E.; Kim, Man J.; Moon, Jangsup; Seong, Moon-Woo; Park, Sung S.; Choi, Sun A.; Lee, Ji E.; Kwon, Young S.; Sohn, Young B.; Kim, Jon S.; Kim, Won S.; Lee, Yun J.; Kwon, Soonhak; Kim, Young O.; Kook, Hoon; Cho, Yong G.; Cheon, Chong K.; Kang, Ki-Soo; Song, Mi-Ryoung; Kim, Young-Joon; Cha, Hyuk-Jin; Choi, Hee-Jung; Kee, Yun; Park, Sung-Gyoo; Baek, Seung T.; Choi, Murim; Ryu, Dong-Sung; Chae, Jong-Hee

Issue Date
2022-10-08
Citation
Orphanet Journal of Rare Diseases. 2022 Oct 08;17(1):372
Abstract
Abstract

Background
Phase I of the Korean Undiagnosed Diseases Program (KUDP), performed for 3years, has been completed. The Phase I program aimed to solve the problem of undiagnosed patients throughout the country and develop infrastructure, including a data management system and functional core laboratory, for long-term translational research. Herein, we share the clinical experiences of the Phase I program and introduce the activities of the functional core laboratory and data management system.


Results
During the program (2018–2020), 458 patients were enrolled and classified into 3 groups according to the following criteria: (I) those with a specific clinical assessment which can be verified by direct testing (32 patients); (II) those with a disease group with genetic and phenotypic heterogeneity (353 patients); and (III) those with atypical presentations or diseases unknown to date (73 patients). All patients underwent individualized diagnostic processes based on the decision of an expert consortium. Confirmative diagnoses were obtained for 242 patients (52.8%). The diagnostic yield was different for each group: 81.3% for Group I, 53.3% for Group II, and 38.4% for Group III. Diagnoses were made by next-generation sequencing for 204 patients (84.3%) and other genetic testing for 35 patients (14.5%). Three patients (1.2%) were diagnosed with nongenetic disorders. The KUDP functional core laboratory, with a group of experts, organized a streamlined research pipeline covering various resources, including animal models, stem cells, structural modeling and metabolic and biochemical approaches. Regular data review was performed to screen for candidate genes among undiagnosed patients, and six different genes were identified for functional research. We also developed a web-based database system that supports clinical cohort management and provides a matchmaker exchange protocol based on a matchbox, likely to reinforce the nationwide clinical network and further international collaboration.


Conclusions
The KUDP evaluated the unmet needs of undiagnosed patients and established infrastructure for a data-sharing system and future functional research. The advancement of the KUDP may lead to sustainable bench-to-bedside research in Korea and contribute to ongoing international collaboration.
URI
https://doi.org/10.1186/s13023-022-02520-5

https://hdl.handle.net/10371/186068
Files in This Item:
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share